OX40-targeted fully human monoclonal antibody as well as preparation and application thereof
The invention discloses a fully human monoclonal antibody targeting OX40 as well as preparation and application of the fully human monoclonal antibody. Specifically, the invention provides an antibody targeting OX40, the antibody comprises a light chain variable region and a heavy chain variable reg...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | WANG ZHANYANG GUO LINGHUA QIAN WENZHENG LI ZHEN CHEN XIAOBO YAN YUNQIU WANG GUIQIN LIU LIN |
| description | The invention discloses a fully human monoclonal antibody targeting OX40 as well as preparation and application of the fully human monoclonal antibody. Specifically, the invention provides an antibody targeting OX40, the antibody comprises a light chain variable region and a heavy chain variable region, the light chain variable region comprises LCDR1, LCDR2 and LCDR3 of which amino acid sequences are respectively shown as SEQ ID NO: 3, 4 and 5, and the heavy chain variable region comprises LCDR1, LCDR2 and LCDR3 of which amino acid sequences are respectively shown as SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4 and SEQ ID NO: 5; and/or the heavy chain variable region comprises HCDR1, HCDR2 and HCDR3 of which the amino acid sequences are respectively shown as SEQ ID NO: 8, 9 and 10. The antibody provided by the invention not only can block the combination of an OX40 cell line and OX40L at a low concentration, but also can improve ADCC activity through deglycosylation modification, can mediate apoptosis of effector |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN118359720A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN118359720A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN118359720A3</originalsourceid><addsrcrecordid>eNqNikEKwjAQAHvxIOof1gcUWquoRymKJ7148CCUNdnYwDYbkhTp71X0AZ6GYWac3c7XZZEnDA9KpMH0zAO0fYcOOnGiWBwyoEv2LnoAjPAk5g99II8BkxX37hrQe7bq66mlQGKm2cggR5r9OMnmh_2lPubkpaHoUZGj1NSnstxUq-16Ueyqf54Xhsg7uQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>OX40-targeted fully human monoclonal antibody as well as preparation and application thereof</title><source>esp@cenet</source><creator>WANG ZHANYANG ; GUO LINGHUA ; QIAN WENZHENG ; LI ZHEN ; CHEN XIAOBO ; YAN YUNQIU ; WANG GUIQIN ; LIU LIN</creator><creatorcontrib>WANG ZHANYANG ; GUO LINGHUA ; QIAN WENZHENG ; LI ZHEN ; CHEN XIAOBO ; YAN YUNQIU ; WANG GUIQIN ; LIU LIN</creatorcontrib><description>The invention discloses a fully human monoclonal antibody targeting OX40 as well as preparation and application of the fully human monoclonal antibody. Specifically, the invention provides an antibody targeting OX40, the antibody comprises a light chain variable region and a heavy chain variable region, the light chain variable region comprises LCDR1, LCDR2 and LCDR3 of which amino acid sequences are respectively shown as SEQ ID NO: 3, 4 and 5, and the heavy chain variable region comprises LCDR1, LCDR2 and LCDR3 of which amino acid sequences are respectively shown as SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4 and SEQ ID NO: 5; and/or the heavy chain variable region comprises HCDR1, HCDR2 and HCDR3 of which the amino acid sequences are respectively shown as SEQ ID NO: 8, 9 and 10. The antibody provided by the invention not only can block the combination of an OX40 cell line and OX40L at a low concentration, but also can improve ADCC activity through deglycosylation modification, can mediate apoptosis of effector</description><language>chi ; eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PHYSICS ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROCESSES USING MICROORGANISMS ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; TESTING ; VINEGAR ; WINE</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240719&DB=EPODOC&CC=CN&NR=118359720A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240719&DB=EPODOC&CC=CN&NR=118359720A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WANG ZHANYANG</creatorcontrib><creatorcontrib>GUO LINGHUA</creatorcontrib><creatorcontrib>QIAN WENZHENG</creatorcontrib><creatorcontrib>LI ZHEN</creatorcontrib><creatorcontrib>CHEN XIAOBO</creatorcontrib><creatorcontrib>YAN YUNQIU</creatorcontrib><creatorcontrib>WANG GUIQIN</creatorcontrib><creatorcontrib>LIU LIN</creatorcontrib><title>OX40-targeted fully human monoclonal antibody as well as preparation and application thereof</title><description>The invention discloses a fully human monoclonal antibody targeting OX40 as well as preparation and application of the fully human monoclonal antibody. Specifically, the invention provides an antibody targeting OX40, the antibody comprises a light chain variable region and a heavy chain variable region, the light chain variable region comprises LCDR1, LCDR2 and LCDR3 of which amino acid sequences are respectively shown as SEQ ID NO: 3, 4 and 5, and the heavy chain variable region comprises LCDR1, LCDR2 and LCDR3 of which amino acid sequences are respectively shown as SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4 and SEQ ID NO: 5; and/or the heavy chain variable region comprises HCDR1, HCDR2 and HCDR3 of which the amino acid sequences are respectively shown as SEQ ID NO: 8, 9 and 10. The antibody provided by the invention not only can block the combination of an OX40 cell line and OX40L at a low concentration, but also can improve ADCC activity through deglycosylation modification, can mediate apoptosis of effector</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PHYSICS</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROCESSES USING MICROORGANISMS</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>TESTING</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNikEKwjAQAHvxIOof1gcUWquoRymKJ7148CCUNdnYwDYbkhTp71X0AZ6GYWac3c7XZZEnDA9KpMH0zAO0fYcOOnGiWBwyoEv2LnoAjPAk5g99II8BkxX37hrQe7bq66mlQGKm2cggR5r9OMnmh_2lPubkpaHoUZGj1NSnstxUq-16Ueyqf54Xhsg7uQ</recordid><startdate>20240719</startdate><enddate>20240719</enddate><creator>WANG ZHANYANG</creator><creator>GUO LINGHUA</creator><creator>QIAN WENZHENG</creator><creator>LI ZHEN</creator><creator>CHEN XIAOBO</creator><creator>YAN YUNQIU</creator><creator>WANG GUIQIN</creator><creator>LIU LIN</creator><scope>EVB</scope></search><sort><creationdate>20240719</creationdate><title>OX40-targeted fully human monoclonal antibody as well as preparation and application thereof</title><author>WANG ZHANYANG ; GUO LINGHUA ; QIAN WENZHENG ; LI ZHEN ; CHEN XIAOBO ; YAN YUNQIU ; WANG GUIQIN ; LIU LIN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN118359720A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2024</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PHYSICS</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROCESSES USING MICROORGANISMS</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>TESTING</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>WANG ZHANYANG</creatorcontrib><creatorcontrib>GUO LINGHUA</creatorcontrib><creatorcontrib>QIAN WENZHENG</creatorcontrib><creatorcontrib>LI ZHEN</creatorcontrib><creatorcontrib>CHEN XIAOBO</creatorcontrib><creatorcontrib>YAN YUNQIU</creatorcontrib><creatorcontrib>WANG GUIQIN</creatorcontrib><creatorcontrib>LIU LIN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WANG ZHANYANG</au><au>GUO LINGHUA</au><au>QIAN WENZHENG</au><au>LI ZHEN</au><au>CHEN XIAOBO</au><au>YAN YUNQIU</au><au>WANG GUIQIN</au><au>LIU LIN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>OX40-targeted fully human monoclonal antibody as well as preparation and application thereof</title><date>2024-07-19</date><risdate>2024</risdate><abstract>The invention discloses a fully human monoclonal antibody targeting OX40 as well as preparation and application of the fully human monoclonal antibody. Specifically, the invention provides an antibody targeting OX40, the antibody comprises a light chain variable region and a heavy chain variable region, the light chain variable region comprises LCDR1, LCDR2 and LCDR3 of which amino acid sequences are respectively shown as SEQ ID NO: 3, 4 and 5, and the heavy chain variable region comprises LCDR1, LCDR2 and LCDR3 of which amino acid sequences are respectively shown as SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4 and SEQ ID NO: 5; and/or the heavy chain variable region comprises HCDR1, HCDR2 and HCDR3 of which the amino acid sequences are respectively shown as SEQ ID NO: 8, 9 and 10. The antibody provided by the invention not only can block the combination of an OX40 cell line and OX40L at a low concentration, but also can improve ADCC activity through deglycosylation modification, can mediate apoptosis of effector</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_CN118359720A |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROCESSES USING MICROORGANISMS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS TESTING VINEGAR WINE |
| title | OX40-targeted fully human monoclonal antibody as well as preparation and application thereof |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T16%3A15%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WANG%20ZHANYANG&rft.date=2024-07-19&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN118359720A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |